In contrast, NKILA interacts with mir-582-3p regulated by m6A methyltransferase METTL3 and inhibits its expression, thereby accelerating cholangiocarcinoma progression through YAP1 [34]. This evidence concerns the gene METTL3 and cholangiocarcinoma.